Paul Brown - Articles and news items

Roche logo

FDA approves Zelboraf (vemurafenib)

Industry news, News / 17 August 2011 / Roche

First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma…

Roche logo

Roche announces vemurafenib improved survival in people with metastatic melanoma who have BRAF V600 mutations

Industry news, News / 5 June 2011 / Roche

Roche announced that a Phase III study (BRIM3) showed vemurafenib (RG7204, PLX4032) significantly improved overall survival in people with previously untreated BRAF V600 mutation…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...